Check out our work on the ACE2 microbody as a potent inhibitor of the SARS-CoV-2 virus published in Cell Reports. Congratulations and...

CARISMA Therapeutics Inc. now shares the license to use the vpx lentiviral vector created in our lab to facilitate the development of...

Lentiviral vector-based dendritic cell vaccine suppresses HIV replication in humanized mice Thomas D. Norton1,2*, Anjie Zhen3*, Takuya...

Dr. Nathaniel Landau appeared in the Documentary “The Battle of AmfAR”, which premiered on Dec. 2, 9pm on HBO. The documentary is...

Dr. Landau joins the TWiV team to discuss restriction of HIV replication by SAMHD1, and a viral antagonist that can be used to produce a...

Check out the article in the spring 2019 issue of the NYU Langone Health magazine. https://nyulangone.org/news/nyu-school-medicine-resea...